financetom
Business
financetom
/
Business
/
KBR to Provide Ammonia Technology to KazAzot in Kazakhstan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KBR to Provide Ammonia Technology to KazAzot in Kazakhstan
Dec 18, 2024 7:52 AM

10:30 AM EST, 12/18/2024 (MT Newswires) -- KBR (KBR) said Wednesday that KazAzot has chosen its Purifier ammonia technology for Kazakhstan's first "world-scale" fertilizer plant.

The firm said it will supply the technology license, engineering design, equipment, and catalysts for KazAzot's 2,000 metric tons per day ammonia plant in Aktau.

The project will help meet the food security needs of Kazakhstan and neighboring countries, the company added.

Price: 56.48, Change: -0.34, Percent Change: -0.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EVgo Closes $1.25 Billion DOE Loan Facility to Fund Charging Network Expansion
EVgo Closes $1.25 Billion DOE Loan Facility to Fund Charging Network Expansion
Dec 12, 2024
04:53 PM EST, 12/12/2024 (MT Newswires) -- EVgo ( EVGO ) said Thursday that it closed a $1.25 billion guaranteed loan facility from the US Department of Energy's Loan Programs Office. The loan facility is under the department's Title 17 clean energy financing program that will support the company's efforts to build 7,500 new fast-charging stalls nationwide, according to EVgo...
Corcept Therapeutics Phase 4 Trial of Korlym Shows Hemoglobin A1c Reduction in Patients With Hypercortisolism, Diabetes
Corcept Therapeutics Phase 4 Trial of Korlym Shows Hemoglobin A1c Reduction in Patients With Hypercortisolism, Diabetes
Dec 12, 2024
04:54 PM EST, 12/12/2024 (MT Newswires) -- Corcept Therapeutics ( CORT ) said late Thursday that its phase 4 Catalyst trial of Korlym showed a reduction in hemoglobin A1c in patients with hypercortisolism, or Cushing's syndrome, and difficult-to-control type 2 diabetes, meeting the study's primary endpoint. Korlym-treated patients demonstrated a 1.47% reduction in hemoglobin A1c, compared with a 0.15% decrease...
Australia's Insignia Financial gets $1.7 billion takeover offer from Bain Capital
Australia's Insignia Financial gets $1.7 billion takeover offer from Bain Capital
Dec 12, 2024
(Reuters) -Australia's Insignia Financial ( IOOFF ) said on Friday it has received a non-binding takeover all-cash proposal from private equity Bain Capital, valuing the wealth manager at A$2.67 billion ($1.70 billion). The offer price of A$4.00 per share represents a 17.6% premium to the stock's closing price of A$3.40 per share on Thursday. Insignia's shares had been trading at...
Symbotic Acquires Robotics Company OhmniLabs
Symbotic Acquires Robotics Company OhmniLabs
Dec 12, 2024
04:54 PM EST, 12/12/2024 (MT Newswires) -- Symbotic ( SYM ) said late Thursday it has closed its acquisition of robotics company OhmniLabs. The company said OhmniLabs offers autonomous disinfection and telepresence robots. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved